glabridin

Glabridin (KB-289522) may serve as an anti-inflammatory agent in diabetes-related vascular dysfunction, through regulating the synthesis and activity of iNOS under high-glucose levels; may possess a therapeutic effect on metabolic disorders( such as diabetes and hyperglycemia), by modulating glucose metabolism through AMPK in skeletal muscle cells. Glabridin may have potential as a chemopreventive agent against liver Y metastasis, by inhibiting the invasion of human HCC cells.

Preglabridin is a useful organic compound for research related to life sciences and the catalog number is T129460.

3′-Hydroxy-4′-O-methylglabridin effectively prevents NADH-dependent peroxidation, exhibiting potent antioxidant properties [1].

Hispaglabridin A, an effective antioxidant, inhibits lipid peroxidation [1].

3,4-Didehydroglabridin, a compound sourced from licorice, demonstrates protective effects against carbon tetrachloride-induced injury in HepG2 cells, presenting research potential for liver injury therapeutics [1] [2].